FIELD: medicine.
SUBSTANCE: the present innovation deals with diagnostic methods: at detecting normal values of activated partial thromboplastin time (APTT) and kaolin time (KT) in patient's plasma one should detect factors for blood VIII and IX clotting and at increased activity of these factors patient's plasma should be mixed with plasma deficient by corresponding factor at ratio to provide normal activity of these factors in final mixture. The mixture should be incubated at 37 C for 2 h, one should repeatedly detect there APTT value and at excess of normal time for clot development and its normalization after incubating the mixture with phospholipids concentrate at 37 C for 5 min it is possible to diagnose availability of lupus anticoagulant.
EFFECT: higher accuracy of diagnostics.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTING BLOOD CLOTTING FACTOR DEFICIENCY BY THROMBOELASTOMETRY | 2019 |
|
RU2699798C1 |
METHOD FOR DIAGNOSING ANTIPHOSPHOLIPID SYNDROME | 1995 |
|
RU2104550C1 |
METHOD FOR DETERMINING LUPUS ERYTHEMATOSUS ANTICOAGULANT AVAILABILITY | 1999 |
|
RU2181203C2 |
HIGHLY-SELECTIVE INFESTIN 4-BASED INHIBITOR OF CONTACT ACTIVATION | 2013 |
|
RU2556116C2 |
DIMETHYL 7-METHYL-2-n-TOLYL-4-PHENYLPYRROLO[2,1-f] [2,1,4]TRIAZINE-5,6-DICARBOXYLATE WITH ANTICOAGULANT EFFECT | 2022 |
|
RU2790375C1 |
DETERMINATION OF INTERNATIONAL NORMALIZED RATIO (INR) BASED ON CAPILLARY BLOOD PROTHROMBIN TIME (PT) | 2005 |
|
RU2271004C1 |
MODIFIED DNA APTAMERS INHIBITING THROMBIN ACTIVITY | 2009 |
|
RU2410432C1 |
METHOD FOR OBTAINING A LIOPHILIZED PREPARATION OF AN ACTIVATED PROTROMBIN COMPLEX HAVING VIII-SHUNTING ACTIVITY FACTOR | 2017 |
|
RU2648517C1 |
METHOD OF ESTIMATING CONDITION OF BLOOD COAGULATION SYSTEM IN PATIENTS IN CRITICAL CONDITION | 2012 |
|
RU2517116C2 |
APTAMER OLIGONUCLEOTIDE - DIRECT THROMBIN INHIBITOR | 2008 |
|
RU2401306C2 |
Authors
Dates
2004-10-27—Published
2003-01-23—Filed